| The role of PET/computed tomography scan in the management of prostate cancer. | |
| | |
MedLine Citation:
|
PMID: 21378572 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
PURPOSE OF REVIEW: To evaluate the role of PET/computed tomography (CT) imaging in patients with prostate cancer and to provide clinical recommendations, both in pretreatment and in post-treatment phase. RECENT FINDINGS: The potential role of PET/CT for evaluating intraprostatic disease, staging and restaging prostate cancer patients has been largely investigated. In particular, among the different PET tracers evaluated, choline, acetate and fluoride are showing the most promising results for imaging prostate cancer and its metastases. However, although choline PET/CT is an established diagnostic tool for imaging prostate cancer patients, as documented by a large amount of literature, further studies are still necessary to establish the final clinical role of PET/CT with acetate and fluoride. SUMMARY: Choline PET/CT is clinically indicated to noninvasively restage, in one single session, prostate cancer patients presenting a progressive increase of prostate-specific antigen, after radical treatment. Conversely, choline PET/CT does not allow the accurate assessment of intraprostatic tumor and of small lymph nodal involvement, thus not being currently recommended as a first-line method for initial diagnosis and staging. The current use of PET/CT with acetate and fluoride in clinical practice still needs further confirmations. |
| | |
Authors:
|
Maria Picchio; Elisabetta Giovannini; Cristina Messa |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-3-3 |
Journal Detail:
|
Title: Current opinion in urology Volume: - ISSN: 1473-6586 ISO Abbreviation: - Publication Date: 2011 Mar |
Date Detail:
|
Created Date: 2011-3-7 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9200621 Medline TA: Curr Opin Urol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
aDepartment of Nuclear Medicine, San Raffaele Scientific Institute, Italy bInstitute for Bioimaging and Molecular Physiology, National Research Council, Italy cCenter for Molecular Bioimaging, University of Milano-Bicocca, Milan, Italy dDepartment of Nuclear Medicine, San Gerardo Hospital, Monza, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Robotic radical prostatectomy: a critical analysis of surgical quality.
Next Document: Smoking-attributable Mortality in the United States.